Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

igr Genes and Mycobacterium tuberculosis cholesterol metabolism.

Chang JC, Miner MD, Pandey AK, Gill WP, Harik NS, Sassetti CM, Sherman DR.

J Bacteriol. 2009 Aug;191(16):5232-9. doi: 10.1128/JB.00452-09. Epub 2009 Jun 19.

2.

Role of cholesterol in Mycobacterium tuberculosis infection.

Miner MD, Chang JC, Pandey AK, Sassetti CM, Sherman DR.

Indian J Exp Biol. 2009 Jun;47(6):407-11. Review.

PMID:
19634704
3.

An insight into the regulation of mce4 operon of Mycobacterium tuberculosis.

Rathor N, Chandolia A, Saini NK, Sinha R, Pathak R, Garima K, Singh S, Varma-Basil M, Bose M.

Tuberculosis (Edinb). 2013 Jul;93(4):389-97. doi: 10.1016/j.tube.2013.03.007. Epub 2013 Apr 24.

PMID:
23622789
4.

Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism.

Thomas ST, VanderVen BC, Sherman DR, Russell DG, Sampson NS.

J Biol Chem. 2011 Dec 23;286(51):43668-78. doi: 10.1074/jbc.M111.313643. Epub 2011 Nov 1.

5.

Mycobacterial gene cuvA is required for optimal nutrient utilization and virulence.

Mir M, Prisic S, Kang CM, Lun S, Guo H, Murry JP, Rubin EJ, Husson RN.

Infect Immun. 2014 Oct;82(10):4104-17. doi: 10.1128/IAI.02207-14. Epub 2014 Jul 21.

6.

Mycobacterial persistence requires the utilization of host cholesterol.

Pandey AK, Sassetti CM.

Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4376-80. doi: 10.1073/pnas.0711159105. Epub 2008 Mar 11. Erratum in: Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9130.

7.
8.
9.

Functional characterization of a vitamin B12-dependent methylmalonyl pathway in Mycobacterium tuberculosis: implications for propionate metabolism during growth on fatty acids.

Savvi S, Warner DF, Kana BD, McKinney JD, Mizrahi V, Dawes SS.

J Bacteriol. 2008 Jun;190(11):3886-95. doi: 10.1128/JB.01767-07. Epub 2008 Mar 28.

10.
11.

A thiolase of Mycobacterium tuberculosis is required for virulence and production of androstenedione and androstadienedione from cholesterol.

Nesbitt NM, Yang X, Fontán P, Kolesnikova I, Smith I, Sampson NS, Dubnau E.

Infect Immun. 2010 Jan;78(1):275-82. doi: 10.1128/IAI.00893-09. Epub 2009 Oct 12.

12.

mosR, a novel transcriptional regulator of hypoxia and virulence in Mycobacterium tuberculosis.

Abomoelak B, Hoye EA, Chi J, Marcus SA, Laval F, Bannantine JP, Ward SK, Daffé M, Liu HD, Talaat AM.

J Bacteriol. 2009 Oct;191(19):5941-52. doi: 10.1128/JB.00778-09. Epub 2009 Jul 31.

13.

Mycobacterium tuberculosis strains disrupted in mce3 and mce4 operons are attenuated in mice.

Senaratne RH, Sidders B, Sequeira P, Saunders G, Dunphy K, Marjanovic O, Reader JR, Lima P, Chan S, Kendall S, McFadden J, Riley LW.

J Med Microbiol. 2008 Feb;57(Pt 2):164-70. doi: 10.1099/jmm.0.47454-0.

PMID:
18201981
14.

Cholesterol oxidase is required for virulence of Mycobacterium tuberculosis.

Brzostek A, Dziadek B, Rumijowska-Galewicz A, Pawelczyk J, Dziadek J.

FEMS Microbiol Lett. 2007 Oct;275(1):106-12. Epub 2007 Jul 25.

15.

Attenuation of late-stage disease in mice infected by the Mycobacterium tuberculosis mutant lacking the SigF alternate sigma factor and identification of SigF-dependent genes by microarray analysis.

Geiman DE, Kaushal D, Ko C, Tyagi S, Manabe YC, Schroeder BG, Fleischmann RD, Morrison NE, Converse PJ, Chen P, Bishai WR.

Infect Immun. 2004 Mar;72(3):1733-45.

16.

Mutation in mce operons attenuates Mycobacterium tuberculosis virulence.

Gioffré A, Infante E, Aguilar D, Santangelo MP, Klepp L, Amadio A, Meikle V, Etchechoury I, Romano MI, Cataldi A, Hernández RP, Bigi F.

Microbes Infect. 2005 Mar;7(3):325-34. Epub 2005 Feb 1.

PMID:
15804490
17.

Mycobacterium tuberculosis is able to accumulate and utilize cholesterol.

Brzostek A, Pawelczyk J, Rumijowska-Galewicz A, Dziadek B, Dziadek J.

J Bacteriol. 2009 Nov;191(21):6584-91. doi: 10.1128/JB.00488-09. Epub 2009 Aug 28.

18.
19.

Urease activity represents an alternative pathway for Mycobacterium tuberculosis nitrogen metabolism.

Lin W, Mathys V, Ang EL, Koh VH, Martínez Gómez JM, Ang ML, Zainul Rahim SZ, Tan MP, Pethe K, Alonso S.

Infect Immun. 2012 Aug;80(8):2771-9. doi: 10.1128/IAI.06195-11. Epub 2012 May 29.

20.

Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth.

Steyn AJ, Collins DM, Hondalus MK, Jacobs WR Jr, Kawakami RP, Bloom BR.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3147-52.

Items per page

Supplemental Content

Write to the Help Desk